Oasmia Pharmaceutical AB Other Operating Income Expense
Oasmia Pharmaceutical AB reported Other Operating Income Expense of SEK 1.75 million for the 12-month period ending 2018-04-30, per its 20-F filed 2018-09-14.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:OtherOperatingIncomeExpense · last filed 2018-09-14
| Period end | Other Operating Income Expense 12 month |
|---|---|
| 2018-04-30 | 1.75M SEK 20-F · filed 2018-09-14 |
| 2017-04-30 | 420.00K SEK 20-F · filed 2018-09-14 |
| 2016-04-30 | 2.00K SEK 20-F · filed 2018-09-14 |